Later-Line Combination Therapies Used as Treatment in Multiple Myeloma

home / case-based-roundtable-series / later-line-combination-therapies-used-as-treatment-in-multiple-myeloma

This roundtable series considers the use of combination treatments in patients with relapsed/refractory multiple myeloma who have received 2 or more lines of therapy, as discussed by key opinion leaders and participants at virtual live events.

Next-Line Therapy Choices in R/R Multiple Myeloma After VRd Plus ASCT

Targeted Oncology Staff
March 13th 2023

During a Targeted Oncology™ Case-Based Roundtable™ event, Suzanne Lentzsch, MD, PhD, discussed with participants their choice of combination therapy after disease relapse of multiple myeloma.